GTCpFE

Item number	Size	Manual	Delivery time	Price
TGM-T200141-25mg	25 mg	-	5 - 10 business days*	1,440.00€
TGM-T200141-50mg	50 mg	-	5 - 10 business days*	1,877.00€
TGM-T200141-100mg	100 mg	-	5 - 10 business days*	2,371.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Description: GTCpFE, a compound synthesized from Dimethyl fumarate (DMF) and Aspirin (ASA),... more

Close menu

Product information "GTCpFE"

Description: GTCpFE, a compound synthesized from Dimethyl fumarate (DMF) and Aspirin (ASA), inhibits IKKalpha/beta in the NF-kappaB pathway, exhibiting anti-inflammatory activity by preventing p65 from entering the nucleus. It selectively inhibits cancer stem cell (CSC) activity by reducing the growth of mammospheres and the expression of the CD44+CD24- immune phenotype. Furthermore, GTCpFE targets breast cancer stem cells, crucial in aggressive cancer phenotypes that depend on NFkappaB and PGE2. Target: NF-kappaB. Smiles: C(OC1=CC=C(COC(/C=C/C(OCC)=O)=O)C=C1)(=O)C2=C(OC(C)=O)C=CC=C2

Supplier:	TargetMol
Supplier-Nr:	T200141

Properties

MW:	412.39 D
Formula:	C22H20O8

Database Information

Handling & Safety

Storage:	+4°C
Shipping:	+20°C (International: +4°C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

Information about the product reference will follow. more

Close menu

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "GTCpFE"

Write a review